Please use this identifier to cite or link to this item:
Full metadata record
DC FieldValueLanguage
dc.contributorSistema FMUSP-HC: Faculdade de Medicina da Universidade de São Paulo (FMUSP) e Hospital das Clínicas da FMUSP-
dc.contributor.authorGIOLI-PEREIRA, Luciana-
dc.contributor.authorSANTOS, Paulo Caleb Junior Lima-
dc.contributor.authorFERREIRA, Noely Evangelista-
dc.contributor.authorHUEB, Whady Armindo-
dc.contributor.authorKRIEGER, Jose Eduardo-
dc.contributor.authorPEREIRA, Alexandre Costa-
dc.identifier.citationBMC CARDIOVASCULAR DISORDERS, v.12, article ID 61, 8p, 2012-
dc.description.abstractBackground: We investigated whether 9p21 polymorphisms are associated with cardiovascular events in a group of 611 patients enrolled in the Medical, Angioplasty or Surgery Study II (MASS II), a randomized trial comparing treatments for patients with coronary artery disease (CAD) and preserved left ventricular function. Methods: The participants of the MASS II were genotyped for 9p21 polymorphisms (rs10757274, rs2383206, rs10757278 and rs1333049). Survival curves were calculated with the Kaplan-Meier method and compared with the log-rank statistic. We assessed the relationship between baseline variables and the composite end-point of death, death from cardiac causes and myocardial infarction using a Cox proportional hazards survival model. Results: We observed significant differences between patients within each polymorphism genotype group for baseline characteristics. The frequency of diabetes was lower in patients carrying GG genotype for rs10757274, rs2383206 and rs10757278 (29.4%, 32.8%, 32.0%) compared to patients carrying AA or AG genotypes (49.1% and 39.2%, p = 0.01; 52.4% and 40.1%, p = 0.01; 47.8% and 37.9%, p = 0.04; respectively). Significant differences in genotype frequencies between double and triple vessel disease patients were observed for the rs10757274, rs10757278 and rs1333049. Finally, there was a higher incidence of overall mortality in patients with the GG genotype for rs2383206 compared to patients with AA and AG genotypes (19.5%, 11.9%, 11.0%, respectively; p = 0.04). Moreover, the rs2383206 was still significantly associated with a 1.75-fold increased risk of overall mortality (p = 0.02) even after adjustment of a Cox multivariate model for age, previous myocardial infarction, diabetes, smoking and type of coronary anatomy. Conclusions: Our data are in accordance to previous evidence that chromosome 9p21 genetic variation may constitute a genetic modulator in the cardiovascular system in different scenarios. In patients with established CAD, we observed an association between the rs2383206 and higher incidence of overall mortality and death from cardiac causes in patients with multi-vessel CAD.-
dc.description.sponsorshipZerbini Foundation-
dc.description.sponsorshipFAPESP, Sao Paulo, Brazil [Proc. 2010/19668-3, Proc. 2010-17465-8]-
dc.relation.ispartofBMC Cardiovascular Disorders-
dc.subjectCoronary artery disease-
dc.subjectChromosome 9p21-
dc.subject.othergenome-wide association-
dc.subject.otherbrazilian general-population-
dc.subject.othercontrolled clinical-trial-
dc.subject.other3 therapeutic strategies-
dc.subject.otheritalian population-
dc.titleHigher incidence of death in multi-vessel coronary artery disease patients associated with polymorphisms in chromosome 9p21-
dc.rights.holderCopyright BIOMED CENTRAL LTD-
dc.subject.wosCardiac & Cardiovascular Systems-
dc.type.categoryoriginal article-
hcfmusp.relation.referenceAlvim RO, 2012, J HUM HYPERTENS, V26, P340, DOI 10.1038/jhh.2011.102-
hcfmusp.relation.referenceBroadbent HM, 2008, HUM MOL GENET, V17, P806, DOI 10.1093/hmg/ddm352-
hcfmusp.relation.referenceBuysschaert I, 2010, EUR HEART J, V31, P1132, DOI 10.1093/eurheartj/ehq053-
hcfmusp.relation.referenceBurton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911-
hcfmusp.relation.referenceDoria A, 2008, JAMA-J AM MED ASSOC, V300, P2389, DOI 10.1001/jama.2008.649-
hcfmusp.relation.referenceFerreira NE, 2012, ATHEROSCLEROSIS, V221, P131, DOI 10.1016/j.atherosclerosis.2011.12.009-
hcfmusp.relation.referenceFischer M, 2005, CIRCULATION, V111, P855, DOI 10.1161/01.CIR.0000155611.41961.BB-
hcfmusp.relation.referenceGil J, 2006, NAT REV MOL CELL BIO, V7, P667, DOI 10.1038/nrm1987-
hcfmusp.relation.referenceGori F, 2010, BMC MED GENET, V11, DOI 10.1186/1471-2350-11-60-
hcfmusp.relation.referenceHelgadottir A, 2007, SCIENCE, V316, P1491, DOI 10.1126/science.1142842-
hcfmusp.relation.referenceHueb W, 2004, J AM COLL CARDIOL, V43, P1743, DOI 10.1016/j.jacc.2003.08.065-
hcfmusp.relation.referenceHueb W, 2007, CIRCULATION, V115, P1082, DOI 10.1161/CIRCULATIONAHA.106.625475-
hcfmusp.relation.referenceKim WY, 2006, CELL, V127, P265, DOI 10.1016/j.cell.2006.10.003-
hcfmusp.relation.referenceLemmens R, 2009, EUR J HUM GENET, V17, P1287, DOI 10.1038/ejhg.2009.42-
hcfmusp.relation.referenceLin HF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015124-
hcfmusp.relation.referenceMARENBERG ME, 1994, NEW ENGL J MED, V330, P1041, DOI 10.1056/NEJM199404143301503-
hcfmusp.relation.referenceMatarin M, 2008, STROKE, V39, P1586, DOI 10.1161/STROKEAHA.107.502963-
hcfmusp.relation.referenceMcPherson R, 2007, SCIENCE, V316, P1488, DOI 10.1126/science.1142447-
hcfmusp.relation.referenceMuehlschlegel JD, 2010, CIRCULATION, V122, pS60, DOI 10.1161/CIRCULATIONAHA.109.924233-
hcfmusp.relation.referenceMusunuru K, 2010, CIRC-CARDIOVASC GENE, V3, P445, DOI 10.1161/CIRCGENETICS.109.923508-
hcfmusp.relation.referenceMyakishev MV, 2001, GENOME RES, V11, P163, DOI 10.1101/gr.157901-
hcfmusp.relation.referencePalomaki GE, 2010, JAMA-J AM MED ASSOC, V303, P648, DOI 10.1001/jama.2010.118-
hcfmusp.relation.referencePlant SR, 2011, CEREBROVASC DIS, V31, P117, DOI 10.1159/000321510-
hcfmusp.relation.referenceSamani NJ, 2007, NEW ENGL J MED, V357, P443, DOI 10.1056/NEMJoa072366-
hcfmusp.relation.referenceSantos PCJD, 2011, AM J HYPERTENS, V24, P278, DOI 10.1038/ajh.2010.244-
hcfmusp.relation.referenceSaxena R, 2007, SCIENCE, V316, P1331, DOI 10.1126/science.1142358-
hcfmusp.relation.referenceScheffold T, 2011, BMC CARDIOVASC DISOR, V11, DOI 10.1186/1471-2261-11-9-
hcfmusp.relation.referenceSchunkert H, 2008, CIRCULATION, V117, P1675, DOI 10.1161/CIRCULATIONAHA.107.730614-
hcfmusp.relation.referenceScott LJ, 2007, SCIENCE, V316, P1341, DOI 10.1126/science.1142382-
hcfmusp.relation.referenceShen GQ, 2008, J HUM GENET, V53, P144, DOI 10.1007/s10038-007-0230-6-
hcfmusp.relation.referenceVisel A, 2010, NATURE, V464, P409, DOI 10.1038/nature08801-
hcfmusp.relation.referenceWang W, 2010, CARDIOVASC DIABETOL, V9, DOI 10.1186/1475-2840-9-33-
hcfmusp.relation.referenceZee RYL, 2007, STROKE, V38, pE111, DOI 10.1161/STROKEAHA.107.497669-
hcfmusp.relation.referenceZeggini E, 2007, SCIENCE, V316, P1336, DOI 10.1126/science.1142364-
hcfmusp.remissive.sponsorshipFund Zerbini-
Appears in Collections:

Artigos e Materiais de Revistas Científicas - FM/MCP
Departamento de Cardio-Pneumologia - FM/MCP

Artigos e Materiais de Revistas Científicas - HC/InCor
Instituto do Coração - HC/InCor

Artigos e Materiais de Revistas Científicas - LIM/11
LIM/11 - Laboratório de Cirurgia Cardiovascular e Fisiopatologia da Circulação

Artigos e Materiais de Revistas Científicas - LIM/13
LIM/13 - Laboratório de Genética e Cardiologia Molecular

Files in This Item:
File Description SizeFormat 
art_GIOLI-PEREIRA_Higher_incidence_of_death_in_multi_vessel_coronary_2012.PDFpublishedVersion (English)535.05 kBAdobe PDFThumbnail

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.